Zura Bio Ltd. (ZURA)
1.405
+0.16
(+13.31%)
USD |
NASDAQ |
Nov 10, 16:00
1.39
-0.02
(-1.07%)
After-Hours: 20:00
Zura Bio Shareholders Equity (Quarterly) : 177.66M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 177.66M |
| June 30, 2026 | 197.08M |
| March 31, 2026 | 216.90M |
| December 31, 2025 | 101.54M |
| September 30, 2025 | 108.24M |
| June 30, 2025 | 125.90M |
| March 31, 2025 | 138.20M |
| December 31, 2024 | 146.82M |
| September 30, 2024 | 153.05M |
| June 30, 2024 | 156.52M |
| March 31, 2024 | 61.01M |
| December 31, 2023 | 59.33M |
| Date | Value |
|---|---|
| September 30, 2023 | 63.21M |
| June 30, 2023 | 68.91M |
| March 31, 2023 | 27.86M |
| December 31, 2022 | 133.75M |
| September 30, 2022 | 133.08M |
| June 30, 2022 | 132.62M |
| March 31, 2022 | 130.35M |
| December 31, 2021 | 130.20M |
| September 30, 2021 | 129.09M |
| June 30, 2021 | -0.0272M |
| March 31, 2021 | -0.008M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovelStem International Corp. | -2.032M |
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 564.68M |
| Kezar Life Sciences, Inc. | 65.24M |
| Protara Therapeutics, Inc. | 141.02M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 194.63M |
| Total Liabilities (Quarterly) | 16.97M |
| Current Ratio | 11.29 |